HOME >> BIOLOGY >> NEWS
Modeling human lung cancer

Independent research groups from Sloan-Kettering and MIT have developed mouse models of human lung cancer that shed new light on the initiation and maintenance of the most prevalent form of this disease.

Lung cancer is the leading cause of cancer-related death in the United States. Of the 157,400 people projected to die of lung cancer in the U.S. in 2001, over 40% will be afflicted with pulmonary adenocarcinoma, the most common form of lung cancer. Of these cases, the oncogene K-Ras will be mutated to an active form in about 30%. Thus, the role of K-Ras in cancer development is one of the most actively pursued cancer research topics.

Drs. Tyler Jacks and Harold Varmus at MIT and Sloan-Kettering, respectively, have generated two different conditional mouse models of human lung adenocarcinoma. Both models present significant advantages over existing models. These models are termed conditional because they allow the researcher to turn-on K-Ras gene expression at will and induce tumorigenesis. The two models differ, though, in their regulatory agent and their ability to turn-off K-Ras expression.

Dr. Jacks and colleagues developed a mouse strain that expresses K-Ras upon infection with a genetically engineered virus. Their ability to control the timing, location and multiplicity of tumor initiation affords an unprecedented view into the initial cellular changes associated with pulmonary adenocarcinoma. Using this model, Dr. Jacks and colleagues have discovered a new cell type that is involved in the development of lung cancer.

Dr. Varmus and colleagues developed a mouse strain that expresses the K-Ras gene in a specific subset of lung cells under the control of the oral antibiotic, doxycycline. K-Ras expression is activated when doxycycline is put in their drinking water, and terminated when it is removed from the water.

Dr. Varmus found that when K-Ras expression is activated, the mice develop full-blown lung cancer within t
'"/>

Contact: Nora Poppito
poppito@cshl.org
Cold Spring Harbor Laboratory
14-Dec-2001


Page: 1 2

Related biology news :

1. Molecular Modeling Expands Chemistry Students Experiences
2. Climate change plus human pressure caused large mammal extinctions in late Pleistocene
3. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
4. Most recent common ancestor of all living humans surprisingly recent
5. Wildlife Conservation Society hosts public symposium on human-wildlife diseases
6. Bronfenbrenner book sums up human development
7. No role for simian virus 40 in human pleural mesotheliomas
8. Sugar-coated sea urchin eggs could have sweet implications for human fertility
9. Serotonin metabolites in mollusks suggest pathways for human therapies
10. Wrapping a memory with an experience, capacity for recollection detected in non-human species
11. Viral suspect for amphibian decline traced to human spread through bait

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: